Tag: Covid Vaccine

India Can Achieve 'Herd immunity' After October, But COVID19 Vaccination Needs A Boost: SBI Report
India Can Achieve 'Herd immunity' After October, But COVID19 Vaccination Needs A Boost: SBI Report

India would be able to achieve herd immunity only after October, and the country needs to drastically scale up its vaccination drive, a SBI Ecowrap report said on Friday.

  • Friday, 07 May 2021
Odisha Has Less Covid-19 Vaccine Wastage As Compared To Others: Health Dept
Over 90L COVID19 Vaccine Doses Still Available With States, UTs: Govt

The Centre has provided more than 17.35 crore vaccine doses to the states and the union territories free of cost, and more than 90 lakh doses are still available with them.

  • Friday, 07 May 2021
Odisha Seeks 25 Lakh Doses Of Covishield From Centre
Centre Gave 17.15 Cr Vaccines To States/UTs Free Of Cost

New Delhi: The Ministry of Health and Family Welfare on Thursday said it has so far provided more than 17.15 crore vaccine doses to States/UTs free of cost and more…

  • Thursday, 06 May 2021
Covishield
Odisha Prioritises Vaccination Of Citizens Eligible For 2nd Dose

Bhubaneswar: Amid a shortage of vaccines in Odisha, the State government on Monday put persons eligible for 2nd dose of Covishield vaccine on a priority list. A notification in this…

  • Monday, 03 May 2021
Over 1 Cr COVID Vaccine Doses Still Available With States, UTs: Centre
Over 1 Cr COVID Vaccine Doses Still Available With States, UTs: Centre

New Delhi: More than one crore vaccine doses are still available with states and union territories, and another 80 lakh doses will reach them in the next three days, the…

  • Tuesday, 27 April 2021
Naveen-Patnaik
Odisha Govt Announces Free Covid-19 Vaccination For All Above 18 Years

Bhubaneswar: Odisha Chief Minister Naveen Patnaik on Sunday announced free vaccination for all people above 18 years of age. Addressing the people of the State through video conferencing, Patnaik informed…

  • Sunday, 25 April 2021
Remdesivir Production Will Be Up From 38.80 Lakh Units/Month To 74 Lakh Units/Month By May: MHA
Remdesivir Production Will Be Up From 38.80 Lakh Units/Month To 74 Lakh Units/Month By May: MHA

New Delhi: The Union home ministry said several steps have been taken to augment the production and supply of Remdesivir injections from 38.80 lakh units per month to 74 lakh…

  • Friday, 23 April 2021
Oxford-AstraZeneca's 'Covishield' Gets Expert Panel's Clearance, Awaits DCGI Nod
Covishield Priced At Rs 600/Dose For Pvt Hospitals, Rs 400/Dose For State Govts

New Delhi: Serum Institute of India (SII), the world’s largest vaccine maker, on Wednesday announced a price of Rs 600 per dose for COVID vaccine supplies to private hospitals and…

  • Wednesday, 21 April 2021
naveen-modi
Make Available Covid-19 Vaccine In Open Market, Flexibility In Age Criteria: Odisha CM To PM Modi

Bhubaneswar: Underlining the importance of Centre and States working together as a team to face Covid crisis, Odisha Chief Minister Naveen Patnaik has urged Prime Minister Narendra Modi to scale…

  • Saturday, 17 April 2021
Intelligent-Testing-Strateg
Intelligent Testing Strategy For Being 'Ahead Of Virus': ICMR

New Delhi: The Indian Council of Medical Research on Monday said that India developed an Intelligent Testing Strategy to remain ‘ahead of the virus’ by developing testing infrastructure that is laboratories and other means of testing. According to ICMR, the country now has a capacity of testing 2 lakh samples per day. “India now has […]

  • Friday, 16 April 2021
GSk--GlaxoSmithKline
GSK To Produce One Billion Doses Of Covid-19 Vaccine Booster Next Year

London: Pharmaceutical giant GlaxoSmithKline on Thursday said it plans to produce 1 billion doses of coronavirus vaccine adjuvant, an ingredient that makes vaccines work better, in 2021 to support multiple Covid-19 vaccine collaborations. Saying that it has started manufacture of the adjuvant at risk, the company added that it was in discussions with governments and […]

  • Friday, 16 April 2021
COVID-19-vaccine
Johnson & Johnson To Begin Human Trial Of Covid Vaccine In July

New York: Johnson & Johnson on Wednesday said that it has accelerated the first in-human clinical trial of its investigational SARS-CoV-2 vaccine in the second half of July via its Janssen Pharmaceutical Companies (Janssen). The trial for the vaccine, Ad26.COV2-S, recombinant, was initially scheduled to begin in September. “Based on the strength of the preclinical […]

  • Friday, 16 April 2021
Covaxin
COVID Vaccine: Bharat Biotech Begins Human Trial Of Covaxin In India

Chandigarh: The human trial of Bharat Biotech’s anti-COVID-19 vaccine Covaxin began at Rohtak’s Post-Graduate Institute of Medical Sciences on Friday, Haryana Health Minister Anil Vij tweeted. In his tweet, the minister also said the vaccine has been administered to three persons who have shown no adverse effect to it. “Human trial with Corona vaccine (COVAXIN) […]

  • Thursday, 15 April 2021
Covaxin's Phase-3 Trials Begin: Bharat Biotech
AIIMS To Begin COVID Vaccine Human Trial From Next Week

New Delhi: In a major development, AIIMS Delhi will begin human trials of India’s first indigenous Covid-19 vaccine, Covaxin, from next week on 100 healthy volunteers aged between 18 and 55. The volunteers will be kept under observation for a period of nearly 150 days. Covaxin is developed by Bharat Biotech in collaboration with the […]

  • Wednesday, 14 April 2021
COVID19 Vaccine in India
Seven Indian Pharma Players Race To Develop COVID-19 Vaccine

New Delhi: At least seven Indian pharma companies are working to develop a vaccine against coronavirus as they join global efforts to find a preventive to check the spread of the deadly virus that has already infected more than 14 million globally. Bharat Biotech, Serum Institute, Zydus Cadila, Panacea Biotec, Indian Immunologicals, Mynvax and Biological […]

  • Wednesday, 14 April 2021
scrollToTop